Want to join the conversation?
$BIIB 2Q15 Q&A: Kasimov of JPMorgan asked a question about aducanumab titration. George answered that BIIB haven’t released the specific details on how the up titration is going to work. All of the patients will undergo that process as they get to their final dose in the study. Company will have more clarity once it begins enrolling patients.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.